Arthritis Drugs Get Nod From EMA ' s CHMP Arthritis Drugs Get Nod From EMA ' s CHMP

Tofacitinib citrate (Xeljanz), two adalimumab (Humira) biosimilars, and one methotrexate hybrid get thumbs up from EMA committee.International Approvals
Source: Medscape Dermatology Headlines - Category: Dermatology Tags: Rheumatology News Alert Source Type: news